ValiRx plc (LON:VAL – Get Free Report) shares dropped 11.1% on Thursday . The company traded as low as GBX 0.23 and last traded at GBX 0.24. Approximately 8,740,852 shares changed hands during mid-day trading, an increase of 65% from the average daily volume of 5,299,421 shares. The stock had previously closed at GBX 0.27.
ValiRx Trading Down 11.1%
The company has a debt-to-equity ratio of 0.27, a current ratio of 5.50 and a quick ratio of 1.27. The stock has a market capitalization of £1.78 million, a PE ratio of -0.26 and a beta of 0.59. The stock’s 50 day simple moving average is GBX 0.29 and its two-hundred day simple moving average is GBX 0.32.
About ValiRx
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Further Reading
- Five stocks we like better than ValiRx
- D-Wave Earnings Looked Weak, But Investors May Be Missing This
- Nebius Upside Expands as AI Feedback Loop Intensifies
- Insider Trades: Okta and Abbott See Buys, Micron Insiders Sell
- Plug Power Flips The Switch On Profitability
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.
